RespiFinder RG Panel CE
For detection and differentiation of viruses and bacteria that can cause respiratory tract infections
The RespiFinder RG Panel is a qualitative multiplex PCR test to detect and differentiate 16 RNA viruses, 2 DNA viruses and 4 bacteria.
The RespiFinder RG Panel CE is intended for in vitro diagnostic use in Europe.
See the online Performance Characteristics.
The RespiFinder RG Panel is based on the SmartFinder technology, a technology that allows a highly complex analysis of multiple targets using real-time PCR. The RespiFinder RG Panel contains 23 different MultiFinder probe sets combined with 13 fluorescent-labeled SMART (single-tube multiplex amplification in real time) probes that enable the detection of 22 different pathogens, plus an internal control (see table "Pathogens and corresponding target genes of the RespiFinder RG Panel").
The RespiFinder RG Panel uses the Rotor-Gene Q MDx instrument for the detection of the pathogen(s) nucleic acids.
An internal control (IC) is included in the assay to discriminate between true negative samples and false-negative samples due to nucleic acid degradation, PCR inhibition, or test failure.
The input sample is total nucleic acids extracted and purified from nasopharyngeal swabs using the QIAamp MinElute Virus Spin Kit.
The RespiFinder RG Panel contains primers, probes, enzymes and reagents for detection and differentiation of pathogen nucleic acids. Pre-amplification and hybridization are carried out on a standard block-based thermal cycler, followed by ligation and PCR on the Rotor-Gene Q MDx instrument. Melting curve analysis on Rotor-Gene Q MDx enables differentiation of the pathogen nucleic acid targets.
The RespiFinder RG Panel is for in vitro diagnostic use for detection and differentiation of viruses and bacteria that can cause respiratory tract infections in humans.
fragment fix placeholder